How GLP-1s tanked and reshaped the medtech stock market | Mass Device
— Premium direct hire recruitment for executive, engineering, and professional roles. We are Specialized Employment Consultants with a passion for unleashing the full potential of the candidates and clients that we represent.
Aug 1, 2024
Promising clinical trial results on glucagon-like peptide 1 agonists (GLP-1s) created a seismic shift in the medtech stock market.